Using Modified Cytokines to Target Immune Receptors for Selective Response Towards Cancer

Time: 4:45 pm
day: Conference Day One


  • Designing modified cytokines that have low affinity/activity towards their natural receptors
  • How to use induced proximity to restore/drive interactions between the modified cytokine and its natural receptor(s)
  • Optimizing selectivity/pharmacology of the modified cytokine by focusing on localizing activity to clinically relevant targets for alleviating disease